Nuclear Radiology: Page 71

IsoRay nets revenue gain in Q3
By AuntMinnieEurope.com staff writers
A 21% increase in patient cases helped medical isotope developer IsoRay Medical to a third-quarter revenue gain and a lower net loss compared to the same quarter of the prior year.
May 16, 2011
GE to sell MPI stress agent in Europe
By AuntMinnieEurope.com staff writers
GE Healthcare has signed an agreement with Rapidscan Pharma Solutions to sell that company's pharmacological stress agent for myocardial perfusion imaging (MPI) studies in Europe.
May 15, 2011
PET/CT changes status in more than a third of cases
By Rebekah Moan
When the capacity of PET/CT is unlimited, using the modality causes a change in diagnosis, staging, or treatment plan in more than a third of cancer patients, Danish researchers note in the June print edition of European Radiology.
May 12, 2011
IBA revenues increase by 20% in Q1
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
PET/CT helps target radiation therapy of NSCLC tumors
By Becky McCall
LONDON - PET/CT prior to radiotherapy can help oncologists target a more powerful dose of radiation to non-small cell lung cancer (NSCLC), whilst keeping dose low in other areas of the organ, according to research presented at this week's European Society for Therapeutic Radiology and Oncology meeting.
May 10, 2011
2011 05 11 14 00 56 747 Estro Clinical 394
Eckert & Ziegler grows Q1 revenues
By AuntMinnieEurope.com staff writers
Earnings from its isotope products segment powered Eckert & Ziegler, parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products, to a prosperous first quarter.
May 2, 2011
IBA buys stake in German PET firm
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) has acquired a minority stake in a German provider of PET radiopharmaceuticals founded by imaging pioneer Willi Kalender, PhD.
April 17, 2011
BIR releases molecular radiotherapy report
By AuntMinnieEurope.com staff writers
The British Institute of Radiology (BIR) has released a report that reviews the status of molecular radiotherapy in the U.K. and provides recommendations to improve its use and effectiveness.
April 14, 2011
OctreoPharm nets financing for PET tracer
By AuntMinnieEurope.com staff writers
German nuclear medicine contrast firm OctreoPharm Sciences has completed financing for the clinical development of its SOMscan PET cancer diagnostic agent.
April 13, 2011
JNM: Cancer patients need cardiac review
By AuntMinnieEurope.com staff writers
While new antitumor agents result in significant benefits for cancer patients, they may also have serious cardiovascular side effects, according to a new study in the April issue of the Journal of Nuclear Medicine.
April 7, 2011
Eckert & Ziegler posts record sales
By AuntMinnieEurope.com staff writers
Eckert & Ziegler, parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products, achieved record sales from ongoing business operations in 2010.
March 29, 2011
Eckert & Ziegler reports prelim 2010 results
By AuntMinnieEurope.com staff writers
Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products reported strong sales during its 2010 fiscal year.
March 15, 2011
Previous Page
Page 71 of 90
Next Page